Khorrami M - Search Results

1

Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer.

Khorrami M, Viswanathan VS, Reddy P, Braman N, Kunte S, Gupta A, Abraham J, Montero AJ, Madabhushi A. Khorrami M, et al. NPJ Breast Cancer. 2023 Aug 11;9(1):67. doi: 10.1038/s41523-023-00574-7. NPJ Breast Cancer. 2023. PMID: 37567880 Free PMC article.

2

Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer.

Khorrami M, Prasanna P, Gupta A, Patil P, Velu PD, Thawani R, Corredor G, Alilou M, Bera K, Fu P, Feldman M, Velcheti V, Madabhushi A. Khorrami M, et al. Cancer Immunol Res. 2020 Jan;8(1):108-119. doi: 10.1158/2326-6066.CIR-19-0476. Epub 2019 Nov 12. Cancer Immunol Res. 2020. PMID: 31719058 Free PMC article.

3

Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade.

Vaidya P, Bera K, Patil PD, Gupta A, Jain P, Alilou M, Khorrami M, Velcheti V, Madabhushi A. Vaidya P, et al. Among authors: khorrami m. J Immunother Cancer. 2020 Oct;8(2):e001343. doi: 10.1136/jitc-2020-001343. J Immunother Cancer. 2020. PMID: 33051342 Free PMC article.

4

Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer.

Jain P, Khorrami M, Gupta A, Rajiah P, Bera K, Viswanathan VS, Fu P, Dowlati A, Madabhushi A. Jain P, et al. Among authors: khorrami m. Front Oncol. 2021 Oct 20;11:744724. doi: 10.3389/fonc.2021.744724. eCollection 2021. Front Oncol. 2021. PMID: 34745966 Free PMC article.

5

Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers.

Braman N, Prasanna P, Bera K, Alilou M, Khorrami M, Leo P, Etesami M, Vulchi M, Turk P, Gupta A, Jain P, Fu P, Pennell N, Velcheti V, Abraham J, Plecha D, Madabhushi A. Braman N, et al. Among authors: khorrami m. Clin Cancer Res. 2022 Oct 14;28(20):4410-4424. doi: 10.1158/1078-0432.CCR-21-4148. Clin Cancer Res. 2022. PMID: 35727603 Free PMC article.

6

Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas.

Beig N, Khorrami M, Alilou M, Prasanna P, Braman N, Orooji M, Rakshit S, Bera K, Rajiah P, Ginsberg J, Donatelli C, Thawani R, Yang M, Jacono F, Tiwari P, Velcheti V, Gilkeson R, Linden P, Madabhushi A. Beig N, et al. Among authors: khorrami m. Radiology. 2019 Mar;290(3):783-792. doi: 10.1148/radiol.2018180910. Epub 2018 Dec 18. Radiology. 2019. PMID: 30561278 Free PMC article.

7

Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.

Khorrami M, Jain P, Bera K, Alilou M, Thawani R, Patil P, Ahmad U, Murthy S, Stephans K, Fu P, Velcheti V, Madabhushi A. Khorrami M, et al. Lung Cancer. 2019 Sep;135:1-9. doi: 10.1016/j.lungcan.2019.06.020. Epub 2019 Jul 5. Lung Cancer. 2019. PMID: 31446979 Free PMC article.

8

Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma.

Khorrami M, Khunger M, Zagouras A, Patil P, Thawani R, Bera K, Rajiah P, Fu P, Velcheti V, Madabhushi A. Khorrami M, et al. Radiol Artif Intell. 2019 Mar 20;1(2):e180012. doi: 10.1148/ryai.2019180012. Radiol Artif Intell. 2019. PMID: 32076657 Free PMC article.

9

Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans.

Khorrami M, Bera K, Thawani R, Rajiah P, Gupta A, Fu P, Linden P, Pennell N, Jacono F, Gilkeson RC, Velcheti V, Madabhushi A. Khorrami M, et al. Eur J Cancer. 2021 May;148:146-158. doi: 10.1016/j.ejca.2021.02.008. Epub 2021 Mar 17. Eur J Cancer. 2021. PMID: 33743483 Free PMC article.

10

Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab.

Jazieh K, Khorrami M, Saad A, Gad M, Gupta A, Patil P, Viswanathan VS, Rajiah P, Nock CJ, Gilkey M, Fu P, Pennell NA, Madabhushi A. Jazieh K, et al. Among authors: khorrami m. J Immunother Cancer. 2022 Mar;10(3):e003778. doi: 10.1136/jitc-2021-003778. J Immunother Cancer. 2022. PMID: 35256515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page